ArticleArXiv2025
A Workflow to Create a High-Quality Protein-Ligand Binding Dataset for Training, Validation, and Prediction Tasks.
Article in ArXiv, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
9 authors.
Funding
Abstract
Development of scoring functions (SFs) used to predict protein-ligand binding energies requires high-quality 3D structures and binding assay data for training and testing their parameters. In this work, we show that one of the widely-used datasets, PDBbind, suffers from several common structural artifacts of both proteins and ligands, which may compromise the accuracy, reliability, and generalizability of the resulting SFs. Therefore, we have developed a series of algorithms organized in a semi-automated workflow, HiQBind-WF, that curates non-covalent protein-ligand datasets to fix these problems. We also used this workflow to create an independent data set, HiQBind, by matching binding free energies from various sources including BioLiP, Binding MOAD and BindingDB with co-crystalized ligand-protein complexes from the PDB. The resulting HiQBind workflow and dataset are designed to ensure reproducibility and to minimize human intervention, while also being open-source to foster transparency in the improvements made to this important resource for the biology and drug discovery communities.
Identifiers
40093369PMC11908357What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.